Factors other than antimicrobial resistance that promote gastrointestinal colonization by E. faecium have not been identified. We tested the ability of a colonization-proficient clinical E. faecium isolate (C68) to transfer colonizing ability to noncolonizing E. faecium recipient strains. Transconjugants derived from matings that used E. faecium D344SRF as a recipient strain colonized mouse gastrointestinal tracts in high numbers under selective pressure from clindamycin or vancomycin, compared with control strains that lacked DNA transferred from C68. We transferred DNA into a second recipient strain (E. faecium GE-1), which also colonized mice in significantly greater numbers under selective pressure from clindamycin, compared with a control strain. These results indicate that E. faecium clinical isolates express transmissible factors other than antimicrobial resistance that promote colonization of the mouse gastrointestinal tract.
A high level of gastrointestinal colonization by enterococci is a frequent predecessor of serious enterococcal infection and such is promoted by the use of systemic or local antimicrobial agents [1] [2] [3] . Over the past decade, it has been recognized that the worldwide hospital outbreaks and serious infections attributed to multidrugresistant Enterococcus faecium have been the result of the spread of a specific clonal complex (CC), designated CC17 [4, 5] . CC17 strains are characterized by high-level resistance to ampicillin and frequently by resistance to vancomycin and the presence of putative virulence determinants esp Efm (enterococcal surface protein, E. faecium) and hyl Efm (hyaluronidase, E. faecium) [4, 5] . esp Efm has been associated in vitro with increased production of biofilm [6] , although clinical correlations between esp Efm and biofilm formation or other phenotypes have been difficult to establish [7] . To date, there has been no phenotype associated with the expression of hyl Efm .
Although CC17 strains are characterized by resistance to many antimicrobial agents, this resistance alone does not distinguish them from many E. faecium clones that are not associated with outbreaks and clinical infections [4, 5] . It is, therefore, reasonable to postulate that factors other than resistance, such as colonization or virulence factors, may be involved in the emergence and spread of CC17 [4] .
We have previously explored the relationship between antimicrobial therapy and gastrointestinal colonization by multidrug-resistant E. faecium in a mouse model of colonization [1, 8 -10] . We have shown that, much as is observed in the clinical setting, the establishment of murine gastrointestinal colonization is promoted by exposure to broad-spectrum agents that have poor intrinsic antienterococcal activity and are concentrated in the gastrointestinal tract [1, 8 -10] . Ceftriaxone and cefotetan are efficient promoters of colonization in this model, whereas cefepime (which is not excreted into the gastrointestinal tract in significant concentrations) is not. We also observed that antimicrobial agents exhibiting potent activity against anaerobic bacteria promote the persistence of large numbers of enterococci in stool once colonization has been established. Interestingly, we were unable to demonstrate a correlation between antibioticassociated increases in the number of enterococci in the murine upper gastrointestinal tract and reduced numbers of other classes of bacteria [10] .
The strain we have used most frequently in these experiments, E. faecium C68, is a representative of the most prevalent clone found in a citywide survey of vancomycin-resistant enterococci in Cleveland, Ohio, in 1996 [11] . E. faecium C68 exhibits highlevel resistance to ampicillin through multiple mutations in pbp5 and resistance to vancomycin through expression of the vanB operon encoded by transposon Tn5382, as well as resistance to chloramphenicol, clindamycin, erythromycin, gentamicin, streptomycin, and tetracycline [12, 13] . Under appropriate antimicrobial selective pressure, E. faecium C68 readily colonizes the mouse gastrointestinal tract at high levels.
Resistance to ampicillin and vancomycin is readily transferred from E. faecium C68 to E. faecium recipient strains [12] . In the present study, we investigate whether colonization factors other than resistance determinants are transferable from C68 into E. faecium recipient strains.
MATERIALS AND METHODS
Bacterial strains and plasmids. The characteristics of the bacterial strains and plasmids used in these studies are listed in table 1. D344RRF is a derivative of the clinical E. faecium isolate D344R [14] that exhibits elevated levels of resistance to ampicillin and high-level resistance to erythromycin and clindamycin associated with the presence of ermB (data not shown). It has been made resistant to fusidic acid and rifampin in the laboratory by sequential selection on inhibitory concentrations of these 2 antibiotics. E. faecium D344SRF is a spontaneous mutant of D344R in which ampicillin resistance and pbp5 are lost, but high-level resistance to erythromycin and clindamycin persist [14] . It also was made resistant to fusidic acid and rifampin by sequential selection on these 2 antibiotics. E. faecium GE-1 is an ampicillin-susceptible, pbp5 Ϫ , fusidic acid-and rifampinresistant strain [12] that lacks intrinsic resistance to erythromycin and expresses low levels of resistance (for enterococci) to clindamycin (MIC 64 g/mL). E. faecium TUH2-18 is an ampicillin-susceptible clinical isolate with Tn5382 in its genome, kindly provided by Kristen Dahl [17] . pLRM23 is a ϳ220 kb transferable plasmid that encodes hyl Efm in E. faecium C68 (this plasmid is first described in this study).
MICs. MIC determinations were made by use of a broth macrodilution method in accordance with the standards outlined by the Clinical and Laboratory Standards Institute, except that brain-heart infusion (BHI) broth was used instead of Mueller-Hinton broth [18] .
Clonal complex determination. The clonal complex of E. faecium C68 was determined by sequencing the amplified polymerase chain reaction products of 7 housekeeping genes, as described by Willems et al. [5] .
Transferability of pLRM23. Cross-streak mating experiments between E. faecium C68 and either D344SRF or GE-1 were carried out on nonselective BHI agar plates, as described elsewhere [19] . Mating mixtures were resuspended in 1 mL of sterile saline and plated onto 10 ϫ 10 cm BHI agar plates containing fusidic acid (25 g/mL) and rifampin (100 g/mL). Colonies containing pLRM23 were detected by colony hybridization by use of a digoxigenin-labeled amplification product of hyl Efm as a probe (hyl Efm primers: forward primer, 5'-GAGTAGAGGA-ATATCTTAGC-3' and reverse primer, 5'-AGGCTCCAATT-CTGT-3'), as described elsewhere [17] . Hybridized colonies were detected by using an anti-digoxigenin antibody conjugate and a chemiluminescent detection technique (Roche). Transfer of pLRM23 was confirmed by performing plasmid preparations, as described elsewhere [19] , and separating them on 0.7% agarose. Plasmids were transferred from gels to nylon filters by a vacuum procedure, followed by hybridization with the hyl Efm , as described elsewhere [19] . Matings designed to transfer plasmid pAM␤1 into GE-1 were performed using E. faecalis OG1X (pAM␤1) [20] as a donor, as above, with selection on BHI agar plates containing rifampin, fusidic acid, and erythromycin (10 g/mL). Mouse gastrointestinal colonization model. Colonization of mice by enterococcal strains was tested, as described elsewhere [8, 9] . In brief, 25-g female CF1 mice were exposed for 2 days to selecting concentrations of antibiotics (either delivered as 100 mg/mL in the drinking water for vancomycin or 1.2 mg subcutaneously every 12 h for clindamycin). On day 3, the mice were administered an inoculum (the quantity varied from 100 -1000 cfu [low inoculum] to 10 6 -10 7 cfu [high inoculum], depending on the goals of the experiment) of test strain directly into their stomach by gavage. The animals were housed individually, and the cages were cleaned daily. On days 1 and 3 after inoculation, single fresh fecal pellets were recovered from each mouse, weighed, homogenized, and serially diluted to determine the quantity of inoculated strain in the feces by growth on Enterococcosel agar (BD Diagnostic Systems) containing rifampin (100 g/mL) and fusidic acid (25 g/mL), or in some cases, vancomycin (10 g/mL). The lower limit of detection for these experiments was 10 cfu/mL of diluted feces, which in general translated to 2 log 10 cfu/g feces. The animal protocol was reviewed and approved by the Institutional Animal Care and Use Committee of the Louis Stokes Cleveland Veterans Affairs Medical Center.
Statistical analysis. After confirming that the data were normally distributed, we performed a Student's t test to compare the mean log 10 cfu/g of feces. We considered a P value of Ͻ.05 to be statistically significant. [5] of C68 indicated that it was identical to MLS type 16, a member of CC17 and very closely related to the prototype sequence type 17.
RESULTS

Clonal complex determination of E. faecium C68. Multilocus sequence (MLS) analysis
Transfer of hyl Efm . hyl Efm was readily transferred from C68 into D344SRF, using colony hybridization to screen for transconjugants. A plasmid preparation from the donor, recipient, and several transconjugants and hybridization with a hyl Efm probe is shown in figure 1 . Several things are notable about this analysis. The first is that it appears that Ͼ1 plasmid is transferred in each of the transconjugants. Two that appear obvious on the plasmid preparations are approximately 40 kb and 15 kb in size. The second notable feature is that neither of these plasmids hybridizes with the hyl Efm probe. Hybridization is instead found in an area corresponding to the chromosomal band of the plasmid preparation and to the wells of the gel. We interpreted these results as suggesting that hyl Efm was on a plasmid that was too large to effectively enter the gel. We used S1 digestion, pulsed- Rather than a discrete plasmid, the hybridization in the center of the gels likely represents degradation of a very large plasmid, the supercoiled form of which remained largely in the wells.
field gel electrophoresis separation, and Southern hybridization to confirm that hyl Efm was present on a plasmid approximately 220 kb in size (data not shown).
Mouse gastrointestinal colonization by hyl Efm ؉ transconjugants. We compared the ability of 1 D344SRF transconjugant (designated TC 6) to colonize the mouse gastrointestinal with that of parent strain D344RRF, using clindamycin injections to promote colonization. The results for 5 mice in each group are shown in figure 2A . Despite using a high inoculum of D344RRF (ϳ10 6 -10 7 cfu), we were unable to establish significant levels of colonization in any mouse. In contrast, colonization was readily established with TC 6, even when using a low inoculum (ϳ200 cfu). These results did not achieve statistical significance for day 1 (P ϭ .054) but were significant at day 3 (P ϭ .005). The results were essentially the same on day 6 as day 3 (data not shown), so further experiments included only measurements for days 1 and 3. Comparison of colonization abilities of D344SRF transconjugant (TC 6) and parent strain D344RRF. A, Comparison of log 10 cfu/g feces for a high inoculum (ϳ10 6 -10 7 cfu) of D344RRF and a low inoculum (ϳ200 cfu) of TC 6, the transconjugant resulting from a mating between C68 and D344SRF. Asterisk, TC 6 results at day 3 were significantly different from those for D344RRF at the same time point. Each comparison group included 5 mice. B, Comparison of log 10 cfu/g feces between 2 transconjugants resulting from separate matings between C68 and D344SRF. Differences between the 2 strains at both time points were not significant. Each group included 4 mice. Error bars indicate SDs.
To determine whether results were reproducible with a second transconjugant, we chose a transconjugant from a second mating (designated TC H5) and compared that transconjugant's ability to colonize with the ability of TC 6, using a high inoculum of bacteria (ϳ10 7 cfu) . Results are shown in figure 2B . The colonization capacity of TC H5 was equivalent to that of TC 6 in the 4 mice in each group that were tested under these conditions. Colonization under selective pressure from vancomycin. To determine whether therapy with vancomycin conferred the ability to colonize, we performed similar experiments that used orally administered vancomycin as selective pressure. To create strains that could facilitate this comparison, we individually mated D344SRF and TC 6 with TUH2-18, a noncolonizing clinical isolate with a transferable copy of VanB transposon Tn5382 in its genome [17] . Transconjugants were readily obtained with selection on plates containing vancomycin (10 g/mL), fusidic acid, and rifampin. One transconjugant was selected from each mating. The transconjugant resulting from the mating between D344SRF and TUH2-18 (Vm r , hyl Efm Ϫ ) was designated CV206, whereas the transconjugant resulting from the mating between TUH2-18 and TC 6 (Vm rϩ , hyl Efm ϩ ) was designated TUH ϫ 6. The vancomycin MIC for both strains was 128 g/mL. The results of colonization experiments that used a high inoculum of these 2 strains are shown in figure 3 ; these results represent 14 mice tested with TUH ϫ 6 and 4 mice tested with CV206. The differences were statistically significant at both time points, showing that TUH ϫ 6 readily colonized the mouse gastrointestinal tract under selective pressure from vancomycin, while CV206 did not.
Colonization by a different enterococcal strain. We next sought to determine whether the ability to confer colonization was restricted to D344SRF, or whether another enterococcal strain would perform similarly. We mated C68 with E. faecium GE-1, again selecting for transconjugants by colony hybridization, using a hyl Efm probe. We designated the GE-1 transconjugant TC B5. In initial experiments, we compared the ability of GE-1 and TC B5 to colonize under clindamycin selective pressure and observed large differences between the 2 strains, favoring TC B5.
We were concerned that these results could have reflected a difference in clindamycin MICs between the donor and transconjugant. MIC determinations for the 2 strains revealed that GE-1 had a clindamycin MIC of 64 g/mL (typical for E. faecium), whereas TC B5 had an MIC of Ͼ2000 g/mL (reflecting the presence of a constitutively expressed ermB methylase gene transferred on 1 of the non-hyl Efm plasmids from C68). The transfer of this determinant to D344SRF in the earlier experiments had no impact on the D344SRF clindamycin MIC, because that strain has its own copy of ermB and is highly resistant to clindamycin (data not shown).
To control for the expression of erythromycin resistance in these experiments, we mated GE-1 with E. faecalis OG1X (pAM␤1), with selection for transfer of erythromycin resistance, which is conferred by the ermB located on pAM␤1 [20] . One transconjugant was selected and designated GE-1B1. The clindamycin MIC for GE-1B1 was Ͼ2000 g/mL. A comparison of the colonization abilities of GE-1B1 (10 mice) and TC 5b (8 is the result of a mating between TUH2-18 and D344SRF, whereas TUH ϫ 6 (hyl Efm ϩ ) is the result of a mating between TUH2-18 and TC 6. The CV206 ( hyl Efm Ϫ ) group included 4 mice, whereas the TUH ϫ 6 (hyl Efm ϩ ) group included 14 mice. Differences in log 10 cfu/g feces at both time points were statistically significant. Error bars indicate SDs. mice) is shown in figure 4 . GE-1B1 proved to have a modest ability to colonize. However, under these conditions, TC 5B was a more proficient colonizer.
DISCUSSION
The association between antimicrobial therapy and enterococcal gastrointestinal colonization is well established. In general, intrinsic or acquired antimicrobial resistance expressed by enterococci appears to be an important factor in promoting this colonization. Our previous work with the mouse gastrointestinal colonization model indicated that the antibiotic-induced expansion of the enterococcal population occurs throughout the small and large bowel [10] . Although the inhibition of other normal microbial bowel flora and subsequent expansion of enterococci into the void created by their absence make intuitive sense as a mechanism for enterococcal overgrowth, in previous experiments we were unable to demonstrate significant diminution of other measurable species in the small bowel [10] . Diminutions in the populations of bacteria that could not be cultured are, of course, possible, but the results of the present study raise the possibility that factors other than antimicrobial resistance play a role in the likelihood that a specific strain of E. faecium will establish high levels of colonization in the gastrointestinal tract.
CC17 is an E. faecium clonal complex that is strongly associated with clinical infection and hospital outbreaks worldwide [5] . Although CC17 is characterized by multidrug resistance, in particular by resistance to high levels of ampicillin and, in many cases, to vancomycin, this resistance itself does not specifically distinguish CC17 strains from many other strains not associated with outbreaks and clinical infections [5] . CC17 strains are also enriched for esp Efm and hyl Efm [4] , 2 putative virulence determinants, suggesting that these and other factors not related to resistance may play a role in promoting colonization or tissue invasion.
In this study, we have confirmed that E. faecium C68 is a member of CC17. C68 is the strain we have used in our animal enterococcal colonization experiments, initially because it was a representative of the most common vancomycin-resistant Enterococcus clone found in all Cleveland hospitals surveyed in 1996 [11] . We were unaware that C68 might express factors (other than antimicrobial resistance) that promote colonization until we were unable to establish colonization under vancomycin selective pressure with CV206 (a transconjugant resulting from mating between TUH2-18 and D344SRF). Because we knew at this point that the large plasmid pLRM23 was transferable from C68 to D344SRF, and that hyl Efm (but not esp Efm ) was present on pLRM23, we pursued a line of investigation to determine whether factors promoting colonization could be transferred in association with pLRM23.
We have shown that the DNA transfer associated with the movement of hyl Efm confers on transconjugants an ability to colonize the mouse gastrointestinal tract in high numbers. This ability does not appear to be related to the expression of specific antimicrobial resistance determinants, because differences were Figure 4 . Comparison of log 10 cfu/g feces between mice colonized with GE-1B1 (result of mating between E. faecium GE-1 selecting for transfer of resistance to erythromycin encoded by plasmid pAM␤-1) and TC B5, the result of mating between C68 and GE-1, selecting for transfer of hyl Efm . The GE-1B1 group included 8 mice, whereas the TC B5 group included 10 mice. Differences were statistically significant at both time points. Error bars indicate SDs.
observed despite expression of similar levels of resistance to 2 different antibiotics, clindamycin and vancomycin. It is worth noting that we could not achieve colonization with any of these strains in the absence of antimicrobial selective pressure, including C68, which confirms the critical contribution of antimicrobial exposure to enterococcal colonization.
Our results do not appear to be strain specific. Although GE-1 (once it contained the ermB plasmid pAM␤1) was a more proficient colonizer than was D344SRF, addition of the DNA associated with the transfer of hyl Efm augmented levels of colonization.
At the present time, we cannot say with certainty that the colonization factors we have transferred are present on pLRM23. As shown in figure 1 , there are 2 additional plasmids that appear in the hyl Efm ϩ transconjugants. We know that 1 of these other plasmids confers erythromycin resistance through expression of ermB (data not shown). However, colonization proficiency has been transferred on at least 3 separate occasions (twice into D344SRF and once into GE-1) when selection for transconjugants was performed by selecting for transfer of hyl Efm . Therefore, it is reasonable to hypothesize that the colonization determinants are present on pLRM23. Further experiments are planned to determine the colonization proficiency of strains that have the 15-kb and 40-kb plasmids but lack pLRM23. Although we have not yet identified the specific factor(s) responsible for colonization in this model, this report is important in that, to our knowledge, it represents the first confirmation that factors other than antimicrobial resistance are involved in enterococcal gastrointestinal colonization. That these factors are transferable is encouraging, in that it suggests that the genetic regions within which they are contained are relatively limited. Characterization of the transferred DNA may provide an opportunity to use data from other species that may be informative. In Vibrio cholerae, one of the most thoroughly studied intestinal pathogens, expression of the type 4 toxin-coregulated pilus is required for colonization in animal models and in human disease [21] . In Bacteroides melaninogenicus, a representative of the genus that comprises 25% of the gut flora, successful colonization in germ-free mice is dependent on the expression of proteins that facilitate the breakdown of complex carbohydrates like chondroitin sulfate and hyaluronic acid [22] [23] [24] . Therefore, successful gastrointestinal colonization may involve functions that facilitate attachment to or invasion of the gut mucosa, successful competition for energy sources, or both. Preliminary analysis of cloned and sequenced segments pLRM23 reveals at least 4 regions likely to impact carbohydrate use (including the hyl Efm region). One of these regions has been identified as strongly associated with CC17 strains by Leavis et al. [4] . We are actively working to construct deletion mutants of these regions to test gastrointestinal colonization in the mouse model.
